van Crevel R - Search Results - PubMed

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: van Crevel R - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

425 results

Page of 43

Results are displayed in a computed author sort order. The Publication Date timeline is not available.

Page 1

1

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.

Seijger C, Hoefsloot W, Bergsma-de Guchteneire I, Te Brake L, van Ingen J, Kuipers S, van Crevel R, Aarnoutse R, Boeree M, Magis-Escurra C. Seijger C, et al. Among authors: van ingen j, van crevel r. PLoS One. 2019 Mar 14;14(3):e0213718. doi: 10.1371/journal.pone.0213718. eCollection 2019. PLoS One. 2019. PMID: 30870476 Free PMC article.

2

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.

Ruslami R, Nijland HM, Alisjahbana B, Parwati I, van Crevel R, Aarnoutse RE. Ruslami R, et al. Among authors: van crevel r. Antimicrob Agents Chemother. 2007 Jul;51(7):2546-51. doi: 10.1128/AAC.01550-06. Epub 2007 Apr 23. Antimicrob Agents Chemother. 2007. PMID: 17452486 Free PMC article. Clinical Trial.

3

More on tuberculosis.

van Crevel R, Alisjahbana B. van Crevel R, et al. Lancet. 2008 Feb 23;371(9613):647-648. doi: 10.1016/S0140-6736(08)60296-2. Lancet. 2008. PMID: 18295015 No abstract available.

4

High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.

Nijland HM, L'homme RF, Rongen GA, van Uden P, van Crevel R, Boeree MJ, Aarnoutse RE, Koopmans PP, Burger DM. Nijland HM, et al. Among authors: van uden p, van crevel r. AIDS. 2008 May 11;22(8):931-5. doi: 10.1097/QAD.0b013e3282faa71e. AIDS. 2008. PMID: 18453852 Clinical Trial.

5

Clinical experience with the combined use of lopinavir/ritonavir and rifampicin.

L'homme RF, Nijland HM, Gras L, Aarnoutse RE, van Crevel R, Boeree M, Brinkman K, Prins JM, Juttmann JR, Burger DM. L'homme RF, et al. Among authors: van crevel r. AIDS. 2009 Apr 27;23(7):863-5. doi: 10.1097/QAD.0b013e328329148e. AIDS. 2009. PMID: 19352137

6

Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.

Ruslami R, Nijland HM, Adhiarta IG, Kariadi SH, Alisjahbana B, Aarnoutse RE, van Crevel R. Ruslami R, et al. Among authors: van crevel r. Antimicrob Agents Chemother. 2010 Mar;54(3):1068-74. doi: 10.1128/AAC.00447-09. Epub 2009 Dec 28. Antimicrob Agents Chemother. 2010. PMID: 20038625 Free PMC article.

7

Implications of the global increase of diabetes for tuberculosis control and patient care.

Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, van Crevel R. Ruslami R, et al. Among authors: van der ven aj, van crevel r. Trop Med Int Health. 2010 Nov;15(11):1289-99. doi: 10.1111/j.1365-3156.2010.02625.x. Trop Med Int Health. 2010. PMID: 20955495 Free article. Review.

8

SNP/RD typing of Mycobacterium tuberculosis Beijing strains reveals local and worldwide disseminated clonal complexes.

Schürch AC, Kremer K, Hendriks AC, Freyee B, McEvoy CR, van Crevel R, Boeree MJ, van Helden P, Warren RM, Siezen RJ, van Soolingen D. Schürch AC, et al. Among authors: van soolingen d, van helden p, van crevel r. PLoS One. 2011;6(12):e28365. doi: 10.1371/journal.pone.0028365. Epub 2011 Dec 5. PLoS One. 2011. PMID: 22162765 Free PMC article.

9

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.

Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, van Crevel R. Ruslami R, et al. Among authors: van der ven aj, van crevel r. Lancet Infect Dis. 2013 Jan;13(1):27-35. doi: 10.1016/S1473-3099(12)70264-5. Epub 2012 Oct 25. Lancet Infect Dis. 2013. PMID: 23103177 Clinical Trial.

10

Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.

Burhan E, Ruesen C, Ruslami R, Ginanjar A, Mangunnegoro H, Ascobat P, Donders R, van Crevel R, Aarnoutse R. Burhan E, et al. Among authors: van crevel r. Antimicrob Agents Chemother. 2013 Aug;57(8):3614-9. doi: 10.1128/AAC.02468-12. Epub 2013 May 20. Antimicrob Agents Chemother. 2013. PMID: 23689725 Free PMC article.

425 results

Page of 43